Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS
· Delayed Price · Currency is USD
0.0900
0.00 (0.00%)
Feb 21, 2025, 10:00 AM EST
Nymox Pharmaceutical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 0.04 | 0.07 | 1.4 | 0.83 | 3.61 | 5.24 | Upgrade
|
| Cash & Short-Term Investments | 0.04 | 0.07 | 1.4 | 0.83 | 3.61 | 5.24 | Upgrade
|
| Cash Growth | -88.32% | -95.01% | 69.04% | -77.01% | -31.07% | -34.07% | Upgrade
|
| Accounts Receivable | - | - | - | - | - | 0 | Upgrade
|
| Other Receivables | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | Upgrade
|
| Receivables | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | Upgrade
|
| Inventory | - | - | - | 0.03 | 0.03 | 0.02 | Upgrade
|
| Prepaid Expenses | 0.02 | 0.02 | 0.02 | 0.13 | 0.2 | 0.02 | Upgrade
|
| Other Current Assets | 0.54 | 0.53 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
| Total Current Assets | 0.62 | 0.63 | 1.46 | 1.04 | 3.89 | 5.33 | Upgrade
|
| Property, Plant & Equipment | 0 | 0 | 0.17 | 0.41 | 0.45 | 0.16 | Upgrade
|
| Total Assets | 0.62 | 0.63 | 1.63 | 1.44 | 4.34 | 5.49 | Upgrade
|
| Accounts Payable | 4.31 | 3.02 | 1.7 | 1.27 | 1.4 | 1.63 | Upgrade
|
| Accrued Expenses | - | 0.03 | 0.24 | 0.29 | 0.32 | 0.27 | Upgrade
|
| Short-Term Debt | 2.61 | 0.75 | - | - | - | - | Upgrade
|
| Current Portion of Leases | - | - | 0.17 | 0.23 | 0.19 | 0.14 | Upgrade
|
| Other Current Liabilities | - | - | - | - | 0.05 | - | Upgrade
|
| Total Current Liabilities | 6.92 | 3.8 | 2.11 | 1.79 | 1.97 | 2.04 | Upgrade
|
| Long-Term Leases | - | - | - | 0.16 | 0.23 | 0 | Upgrade
|
| Total Liabilities | 6.92 | 3.8 | 2.11 | 1.95 | 2.2 | 2.04 | Upgrade
|
| Common Stock | 173.82 | 173.82 | 171.67 | 165.06 | 151.72 | 136.55 | Upgrade
|
| Additional Paid-In Capital | 27.78 | 27.78 | 26.99 | 27.58 | 31.04 | 35.77 | Upgrade
|
| Retained Earnings | -211.62 | -207.98 | -199.14 | -192.56 | -180.03 | -168.29 | Upgrade
|
| Comprehensive Income & Other | 3.72 | 3.21 | - | -0.59 | -0.59 | -0.59 | Upgrade
|
| Total Common Equity | -6.3 | -3.17 | -0.48 | -0.51 | 2.15 | 3.45 | Upgrade
|
| Shareholders' Equity | -6.3 | -3.17 | -0.48 | -0.51 | 2.15 | 3.45 | Upgrade
|
| Total Liabilities & Equity | 0.62 | 0.63 | 1.63 | 1.44 | 4.34 | 5.49 | Upgrade
|
| Total Debt | 2.61 | 0.75 | 0.17 | 0.39 | 0.43 | 0.15 | Upgrade
|
| Net Cash (Debt) | -2.57 | -0.68 | 1.23 | 0.44 | 3.19 | 5.09 | Upgrade
|
| Net Cash Growth | - | - | 180.18% | -86.22% | -37.45% | -35.92% | Upgrade
|
| Net Cash Per Share | -0.03 | -0.01 | 0.01 | 0.01 | 0.04 | 0.07 | Upgrade
|
| Filing Date Shares Outstanding | 93.54 | 93.54 | 91.27 | 90.28 | 78.71 | 71.97 | Upgrade
|
| Total Common Shares Outstanding | 93.54 | 93.54 | 90.52 | 85.55 | 77.96 | 71.22 | Upgrade
|
| Working Capital | -6.3 | -3.18 | -0.65 | -0.75 | 1.93 | 3.29 | Upgrade
|
| Book Value Per Share | -0.07 | -0.03 | -0.01 | -0.01 | 0.03 | 0.05 | Upgrade
|
| Tangible Book Value | -6.3 | -3.17 | -0.48 | -0.51 | 2.15 | 3.45 | Upgrade
|
| Tangible Book Value Per Share | -0.07 | -0.03 | -0.01 | -0.01 | 0.03 | 0.05 | Upgrade
|
| Machinery | - | 0.6 | 0.59 | 0.59 | 0.59 | 0.58 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.